Ami Bavishi
Investor Relations Kontakt bei RALLYBIO CORPORATION
Aktive Positionen von Ami Bavishi
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| RALLYBIO CORPORATION | Investor Relations Kontakt | 18.01.2022 | - |
| Public Communications Contact | 18.01.2022 | - |
Karriereverlauf von Ami Bavishi
Ehemalige bekannte Positionen von Ami Bavishi
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| AERIE PHARMACEUTICALS, INC. | Investor Relations Kontakt | 02.01.2019 | - |
Ausbildung von Ami Bavishi
| Duquesne University of The Holy Spirit | Undergraduate Degree |
| George Washington University | Graduate Degree |
Statistik
International
| Vereinigte Staaten | 5 |
Operativ
| Investor Relations Contact | 2 |
| Undergraduate Degree | 1 |
| Graduate Degree | 1 |
Sektoral
| Health Technology | 3 |
| Consumer Services | 3 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| RALLYBIO CORPORATION | Health Technology |
| Private Unternehmen | 1 |
|---|---|
Aerie Pharmaceuticals, Inc.
 Aerie Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Aerie Pharmaceuticals, Inc. engages in the discovery, development, and commercialization of therapies for the treatment of patients with open-angle glaucoma, retinal diseases and other diseases of the eye. Its products include Rhopressa, Roclatan, AR-13503, and AR-1105. The company was founded by David L. Epstein, Casey C. Kopczynski, Thomas J. van Haarlem, and Eric J. Toone on January 1, 2005 and is headquartered in Durham, NCForth Worth, TX. | Health Technology |
- Börse
- Insiders
- Ami Bavishi
- Erfahrung
